These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35955591)

  • 1. The Kv10.1 Channel: A Promising Target in Cancer.
    Luis E; Anaya-Hernández A; León-Sánchez P; Durán-Pastén ML
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kv10.1 potassium channel: from the brain to the tumors.
    Cázares-Ordoñez V; Pardo LA
    Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.
    Loza-Huerta A; Milo E; Picones A; Hernández-Cruz A; Luis E
    Pharmacol Rep; 2021 Dec; 73(6):1744-1753. PubMed ID: 34213738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kv10.1 K(+) channel: from physiology to cancer.
    Ouadid-Ahidouch H; Ahidouch A; Pardo LA
    Pflugers Arch; 2016 May; 468(5):751-62. PubMed ID: 26743871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
    Na W; Ma B; Shi S; Chen Y; Zhang H; Zhan Y; An H
    Biochem Pharmacol; 2020 Aug; 178():114089. PubMed ID: 32533968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gamma radiation on functional expression of the voltage-gated potassium channel Kv10.1 and its importance in the radiobiological response.
    Luis E; Lara Figueroa CO; Durán Pastén ML; Azorín Vega EP
    Appl Radiat Isot; 2022 Sep; 187():110331. PubMed ID: 35764005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular hemin is a potent inhibitor of the voltage-gated potassium channel Kv10.1.
    Sahoo N; Yang K; Coburger I; Bernert A; Swain SM; Gessner G; Kappl R; Kühl T; Imhof D; Hoshi T; Schönherr R; Heinemann SH
    Sci Rep; 2022 Aug; 12(1):14645. PubMed ID: 36030326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistate structural modeling and voltage-clamp analysis of epilepsy/autism mutation Kv10.2-R327H demonstrate the role of this residue in stabilizing the channel closed state.
    Yang Y; Vasylyev DV; Dib-Hajj F; Veeramah KR; Hammer MF; Dib-Hajj SD; Waxman SG
    J Neurosci; 2013 Oct; 33(42):16586-93. PubMed ID: 24133262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic expression of the voltage-gated potassium channel KV10.1 promotes disassembly of the primary cilium.
    Sánchez A; Urrego D; Pardo LA
    EMBO Rep; 2016 May; 17(5):708-23. PubMed ID: 27113750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the K
    Barriga-Montoya C; Huanosta-Gutiérrez A; Reyes-Vaca A; Hernández-Cruz A; Picones A; Gómez-Lagunas F
    Pflugers Arch; 2018 Mar; 470(3):491-503. PubMed ID: 29218452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatively Spliced Isoforms of KV10.1 Potassium Channels Modulate Channel Properties and Can Activate Cyclin-dependent Kinase in Xenopus Oocytes.
    Ramos Gomes F; Romaniello V; Sánchez A; Weber C; Narayanan P; Psol M; Pardo LA
    J Biol Chem; 2015 Dec; 290(51):30351-65. PubMed ID: 26518875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel K
    Moreels L; Peigneur S; Galan DT; De Pauw E; Béress L; Waelkens E; Pardo LA; Quinton L; Tytgat J
    Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28902151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K
    Toplak Ž; Merzel F; Pardo LA; Peterlin Mašič L; Tomašič T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Kv10.2 Causes Abnormal Dendritic Arborization and Epilepsy Susceptibility.
    Liu Y; Tang Y; Yan J; Du D; Yang Y; Chen F
    Neurochem Res; 2020 Dec; 45(12):2949-2958. PubMed ID: 33033860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the pharmacological profile of κ-hefutoxin 1 and analogues: A focus on the inhibitory effect on the oncogenic channel K
    Moreels L; Peigneur S; Yamaguchi Y; Vriens K; Waelkens E; Zhu S; Thevissen K; Cammue BPA; Sato K; Tytgat J
    Peptides; 2017 Dec; 98():43-50. PubMed ID: 27578329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism.
    Malak OA; Gluhov GS; Grizel AV; Kudryashova KS; Sokolova OS; Loussouarn G
    J Biol Chem; 2019 Apr; 294(16):6506-6521. PubMed ID: 30808709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liensinine, a Novel and Food-Derived Compound, Exerts Potent Antihepatoma Efficacy via Inhibiting the Kv10.1 Channel.
    Ma B; Shi S; Guo W; Zhang H; Zhao Z; An H
    J Agric Food Chem; 2024 Mar; 72(9):4689-4702. PubMed ID: 38382537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
    Martínez R; Stühmer W; Martin S; Schell J; Reichmann A; Rohde V; Pardo L
    BMC Cancer; 2015 Nov; 15():839. PubMed ID: 26530050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
    Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
    Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KV10.1 K(+)-channel plasma membrane discrete domain partitioning and its functional correlation in neurons.
    Jiménez-Garduño AM; Mitkovski M; Alexopoulos IK; Sánchez A; Stühmer W; Pardo LA; Ortega A
    Biochim Biophys Acta; 2014 Mar; 1838(3):921-31. PubMed ID: 24269539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.